Related references
Note: Only part of the references are listed.Sustained High Levels of Interleukin-6 Contribute to the Pathogenesis of Enterovirus 71 in a Neonate Mouse Model
Wei Xin Khong et al.
JOURNAL OF VIROLOGY (2011)
Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine
Chun-Wei Chen et al.
VACCINE (2011)
Antibody dependent enhancement infection of Enterovirus 71 in vitro and in vivo
Jian-Feng Han et al.
VIROLOGY JOURNAL (2011)
The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes
Guijing Liu et al.
BIOMATERIALS (2010)
Enterovirus 71 Infection of Monocytes with Antibody-Dependent Enhancement
Shih-Min Wang et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Tissue Macrophages Suppress Viral Replication and Prevent Severe Immunopathology in an Interferon-I-Dependent Manner in Mice
Philipp A. Lang et al.
HEPATOLOGY (2010)
Adoptive Transfer of Ex Vivo HO-1 Modified Bone Marrow-derived Macrophages Prevents Liver Ischemia and Reperfusion Injury
Bibo Ke et al.
MOLECULAR THERAPY (2010)
Combined peptides of human enterovirus 71 protect against virus infection in mice
Jiang Ning Liu et al.
VACCINE (2010)
Activin A down-regulates the phagocytosis of lipopolysaccharide-activated mouse peritoneal macrophages in vitro and in vivo
Jing Zhou et al.
CELLULAR IMMUNOLOGY (2009)
An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China
Yong Zhang et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Diseases Caused by Enterovirus 71 Infection
Ta-Chung Lee et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in western blots
D. G. W. Foo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
The molecular basis of mouse adaptation by human enterovirus 71
Beng Hooi Chua et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication
Zhao-Hong Li et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection
Hsiao-Ling Chen et al.
VACCINE (2008)
Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal, challenge
Yao-Chi Chung et al.
VACCINE (2008)
Differentiation of C2D macrophage cells after adoptive transfer
Betsey E. Potts et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Immunity to avirulent enterovirus 71 and coxsackie a16 virus protects against enterovirus 71 infection in mice
Te-Chia Wu et al.
JOURNAL OF VIROLOGY (2007)
Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide
Damian Guang Wei Foo et al.
MICROBES AND INFECTION (2007)
Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity
S.-M. Wang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71
Luan-Yin Chang et al.
PEDIATRIC RESEARCH (2006)
Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71
HF Chen et al.
VACCINE (2006)
Type I interferons protect mice against enterovirus 71 infection
ML Liu et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China
LL Li et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells
TY Weng et al.
ANTIVIRAL RESEARCH (2005)
Age-related changes in the cellular composition of the thymus in children
F Weerkamp et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Age-related changes in polymorphonuclear neutrophil characteristics in infants born to human immunodeficiency virus type 1 seropositive mothers
S Meddows-Taylor et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2004)
Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages
MG Netea et al.
MICROBES AND INFECTION (2004)
A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection
YF Wang et al.
JOURNAL OF VIROLOGY (2004)
Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002
LY Chang et al.
PEDIATRICS (2004)
Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses
P Aichele et al.
JOURNAL OF IMMUNOLOGY (2003)
Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997-2000
LJ Herrero et al.
ARCHIVES OF VIROLOGY (2003)
Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system
TY Lin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Toll-like receptor 4-positive macrophages protect mice from Pasteurella pneumotropica-induced pneumonia
ML Hart et al.
INFECTION AND IMMUNITY (2003)
Seroepidemiology of human enterovirus 71, Singapore
EE Ooi et al.
EMERGING INFECTIOUS DISEASES (2002)
Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan
CY Lu et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Developmental aspects of immunomodulation: exploiting the immature immune system for organ transplantation
LJ West
TRANSPLANT IMMUNOLOGY (2002)
Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus
CN Wu et al.
VACCINE (2001)
Share Paper
